The Gross Margin of CStone Pharmaceuticals (2616.HK) is 58.98%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 58.98% |
| 2023-12-31 | 65.60% |
| 2022-12-31 | 57.83% |
| 2021-12-31 | 56.17% |
| 2020-12-31 | 76.76% |
| 2019-12-31 | 76.76% |